ScholarLens Back to search
2023•Unpublished venueOpen access

Supplementary Tables 1-3 from Sirolimus Therapy for Angiomyolipoma in Tuberous Sclerosis and Sporadic Lymphangioleiomyomatosis: A Phase 2 Trial

D. Mark Davies, Petrus J. de Vries, Simon R. Johnson, Deborah L. McCartney, Jane A. Cox, Andreas L. Serra, Peter Watson, Christopher J. Howe, Tim L. A. Doyle, Kate Pointon, Justin Cross, Anne E. Tattersfield, J. Chris Kingswood, Julian R. Sampson

Open full text 0 citations

Abstract

Supplementary Tables 1-3 from Sirolimus Therapy for Angiomyolipoma in Tuberous Sclerosis and Sporadic Lymphangioleiomyomatosis: A Phase 2 Trial

Open-access reader

About this research paper

What this paper is about

Supplementary Tables 1-3 from Sirolimus Therapy for Angiomyolipoma in Tuberous Sclerosis and Sporadic Lymphangioleiomyomatosis: A Phase 2 Trial

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Supplementary Tables 1-3 from Sirolimus Therapy for Angiomyolipoma in Tuberous Sclerosis and Sporadic Lymphangioleiomyomatosis: A Phase 2 Trial

Key concepts: Tuberous sclerosis, Lymphangioleiomyomatosis, Angiomyolipoma, Sirolimus, Medicine, Dermatology, Internal medicine, Pathology

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Supplementary Tables 1-3 from Sirolimus Therapy for Angiomyolipoma in Tuberous Sclerosis and Sporadic Lymphangioleiomyomatosis: A Phase 2 Trial — Research Paper | ScholarLens